BioGaia (ticker BIOG B) is a Sweden-headquartered biotechnology company listed on Nasdaq Stockholm. The company specializes in probiotic solutions based on patented strains of lactic acid bacteria, primarily within digestive health and immune support. BioGaia operates a B2B-focused model, partnering with pharmaceutical companies and distributors globally to commercialize products across dietary supplements, medical nutrition, and select pharmaceutical applications.
Date
Report
→